Japan’s IVD sector remains highly structured and closely governed, benefiting from a mature healthcare infrastructure and […]
Navigating Japan’s life sciences sector successfully hinges on more than just excellent science or a meticulously […]
It started with a headline I read on the train to kendo practice. AstraZeneca is setting […]
Japan has set ambitious goals to advance its bioeconomy, aiming to integrate biotechnology across various sectors […]
BioStock Global Forum 2024 – May 30, Part II Watch the keynote speech, including the Q&A […]
The shift from using AI as an operational tool to embedding it as a central strategic […]
Understanding the MAH Japan System In Japan, the Marketing Authorization Holder (MAH) is central in the […]
Japanese Market Opportunities in AI-Driven Elderly Care: Living, Health, and Medication Management The silver economy of […]
A Thriving Landscape in Japan’s Pharma Sector Pharma Japan and Strategic Opportunities are plentiful in Japan. […]